Podcast Sponsor: DNAnexus- Unlocking the potential of DNA-based medicine and biotechnology with a collaborative and scalable DNA data management and analysis technology platform.
Stefan Roever, CEO, Genia Technologies Bio and Contact Info
and later Roger Chen, CSO, Genia Technologies Bio and Contact Info
Listen (1:58) 'Last gen' sequencing!?
Listen (6:21) How does the technology work?
Listen (2:17) $100 chip, under $1000 reader
Listen (2:40) What level of analysis?
Listen (2:35) Technology not new, just the application
Listen (3:02) Current progress
Listen (2:51) Advantages over other systems
Listen (10:12) Are tech folks taking over bio?
Listen (2:38) On the verge of something big
Listen (10:02) Roger Chen theorizes about convergence of bio and IT
We’re coming to you from the 4th Personalized Medicine World Conference at the Computer History Museum in Mountain View, CA. Our guests are CEO, Stefan Roever, and CSO, Roger Chen of Genia Technologies. Genia is an emerging company with the aim of developing higher quality, less expensive sequencing for point-of-care.
Stefan is a serial entreprenuer and considered a visionary in the high tech industry. In 1994 he co-founded Brokat Technologies, and as CEO grew the company into a leading provider of Internet banking software with 1,400 employees in 17 countries. Named “Entrepreneur of the Year” in Germany in 1998 by Ernst & Young, Stefan was also ranked by Time magazine as number 11 on its Digital 25 A-List of “25 people who will change the way you work, phone and play.”
Roger Chen has over 10 years of analog/mixed signal electronics experience. He worked at Maxim Integrated Products, an industry leader in analog semiconductors. In 2001, Mr. Chen left Maxim and went back to school. He received his MS in Biochemistry from UC Santa Cruz. Mr. Chen also holds a BS in Electrical Engineering from MIT.